7/7/2023 0 Comments Bio rad stock forecast 2025![]() ![]() is a biotechnology company that is focused on developing precision therapies for genetically defined diseases. In addition to scoring higher than 85 percent of stocks in the Biotechnology industry, COGT’s 72 overall rating means the stock scores better than 72 percent of all stocks. The 72 rating InvestorsObserver gives to Cogent Biosciences Inc stock puts it near the top of the Biotechnology industry. The average price target represents an increase of 95.37% from its latest reported closing price of 11.66. (Nasdaq: COGT), a biotechnology company focused on developing … american museum of natural history nyc The forecasts range from a low of 18.18 to a high of $29.40. and BOULDER, Colo., (GLOBE NEWSWIRE) - Cogent Biosciences, Inc. SVB Securities analyst Christopher Liu reiterated a Buy rating on Cogent Biosciences ( COGT – Research Report) on May 9 and set a price target of $20.00.(COGT) NasdaqGS - NasdaqGS Real Time Price. (COGT) Stock Price, News, Quote & History - Yahoo Finance Cogent Biosciences, Inc. (COGT) stock news and headlines to help you in your trading and investing decisions.Cogent Biosciences, Inc. The forecasts range from a low of 18.18 to a high of $29.40. Analyst Price Forecast Suggests 95.37% Upside As of May 11, 2023, the average one-year price target for Cogent Biosciences is 22.78.Stocks COGT -1.29% Needham Reiterates Cogent Biosciences (COGT) Buy Recommendation 09:42 am EDT Written by George Maybach for Fintel -> Fintel reports that on May 11, 2023.25malx colonial federal savings bank 1 day ago The Company’s advanced clinical program, bezuclastinib (CGT9486), is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT. Get the latest Cogent Biosciences, Inc COGT detailed stock quotes, stock data, Real-Time … View Cogent Biosciences, Inc COGT investment & stock information. ![]() ![]() ![]()
0 Comments
Leave a Reply. |